Physician profile
Joseph R Lynch
NPI 1205944303
$139,962.42
in general payments reported to CMS, 2019-2025
13 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,413 · 2020: $13K · 2021: $34K · 2022: $42K · 2023: $2,810 · 2024: $24K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Education: $17K · Travel and Lodging: $3,624 · Food and Beverage: $3,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,476.06 |
| Education | $16,925.00 |
| Travel and Lodging | $3,624.02 |
| Food and Beverage | $3,348.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $85,558.63 | 2019-2025 | Alliance, Juggerknotless Soft Anchor, Ventix |
| Catalyst Orthoscience | $43,016.83 | 2019-2025 | Catalyst Csr Shoulder System, Catalyst Total Csr, Csr & R1 Reverse Total Shoulder Systems |
| Encore Medical, Lp | $8,284.25 | 2019-2025 | Djo Surgical |
| Depuy Synthes Sales INC. | $1,449.53 | 2025 | |
| Arthrex, INC. | $498.70 | 2020-2023 | Shoulder Implants Speedbridge Composite Anchors, Shoulder Implants Fibertak Knotted |
| Steelhead Surgical INC | $254.59 | 2021-2024 | |
| Sawtooth Surgical Solutions INC | $177.05 | 2024-2025 | |
| Stryker Corporation | $166.06 | 2021-2024 | Tornier Perform Reversed Augmented Glenoid |
| Shoulder Innovations, INC. | $145.37 | 2025 | Inset System |
| Linvatec Corporation | $135.40 | 2024 | Biobrace 23mm |
| Medical Device Business Services, INC. | $109.06 | 2020 | |
| Heron Therapeutics, INC. | $83.92 | 2025 | Zynrelef |
| Wright Medical Technology, INC. | $83.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$569,495.75 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.